Women With Multiple Sclerosis Still Receive Fewer Treatments Than Men
New study reveals persistent sex-based disparities in prescribing disease-modifying therapies for MS
Despite comprising 75% of MS patients, women are significantly less likely than men to receive disease-modifying therapies (DMTs), including highly effective options, even after accounting for pregnancy and disease severity.
Study Details
A comprehensive French registry study analyzed data from over 22,000 people with relapsing-remitting multiple sclerosi…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.